Introduction

As people live longer, the global population of older adults is increasing rapidly. In 2019, there were 703 million individuals aged 65 and older, a number expected to double by 2050. Promoting health and well-being for this age group is a public health priority.

Introduction

Hypoactive sexual desire disorder (HSDD) is a medical condition that affects many women, causing low libido and distress. It has been established that low levels of testosterone can cause low libido in men, and testosterone therapy (TTh) can be an effective treatment option. Testosterone therapy has also shown promise in treating HSDD in women, especially postmenopausal women, improving sexual function and satisfaction.

Introduction

In recent years, there has been a rise in referrals for gender incongruence assessment globally, including in Denmark. Estimating the transgender and gender-diverse population remains challenging, with estimates ranging from 0.02% to 4.5% of the adult population. Individuals experiencing gender incongruence often face psychological vulnerabilities, including depression, anxiety, and increased risk of suicide attempts, alongside reduced quality of life and higher rates of substance abuse.

Introduction

Peyronie’s disease (PD) is a condition that involves plaques forming under the skin of the penis, causing penile abnormalities like indentations or curvature. While most often people with PD experience curvature that is upward or to one side, sometimes individuals have a ventral or downward curvature.

Introduction

An inflatable penile prosthesis (IPP) is a medical device used to treat erectile dysfunction. It is surgically implanted in the penis to help men achieve and maintain an erection suitable for sexual activity.

Introduction

Transgender individuals have a gender identity that differs from their assigned sex at birth. Many transgender individuals are interested in therapies that may help them externally align their physical traits with their internal gender, such as testosterone therapy.